{"count": 23, "results": [{"_id": "32825027", "pmid": 32825027, "pmcid": "PMC7503488", "title": "Metformin as a Potential Agent in the Treatment of Multiple Sclerosis", "journal": "Int J Mol Sci", "authors": ["Dziedzic A", "Saluk-Bijak J", "Miller E", "Bijak M"], "date": "2020-08-19T00:00:00Z", "doi": "10.3390/ijms21175957", "meta_date_publication": "2020 Aug 19", "meta_volume": "21", "meta_issue": "17", "meta_pages": "", "score": 50281.676, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ as a Potential Agent in the Treatment of @<m>DISEASE_Multiple_Sclerosis</m> @DISEASE_MESH:D009103 @@@Multiple Sclerosis@@@", "citations": {"NLM": "Dziedzic A, Saluk-Bijak J, Miller E, Bijak M. Metformin as a Potential Agent in the Treatment of Multiple Sclerosis Int J Mol Sci. 2020 Aug 19;21(17):. PMID: 32825027", "BibTeX": "@article{32825027, title={Metformin as a Potential Agent in the Treatment of Multiple Sclerosis}, author={Dziedzic A and Saluk-Bijak J and Miller E and Bijak M}, journal={Int J Mol Sci}, volume={21}, number={17}}"}}, {"_id": "33650828", "pmid": 33650828, "pmcid": "PMC7944130", "title": "Metformin Protects Myelin from Degeneration in A Mouse Model of Iysophosphatidylcholine-Induced Demyelination in The Optic Chiasm", "journal": "Cell J", "authors": ["Esmaeilnejad S", "Semnanian S", "Javan M"], "date": "2021-04-01T00:00:00Z", "doi": "10.22074/cellj.2021.7174", "meta_date_publication": "2021 Apr", "meta_volume": "23", "meta_issue": "1", "meta_pages": "119-128", "score": 50268.516, "text_hl": "Taken the results of all the above-mentioned studies together, it was hypothesized that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may have positive effects on the pathology of @<m>DISEASE_Multiple_Sclerosis</m> @DISEASE_MESH:D009103 @@@MS@@@. ", "citations": {"NLM": "Esmaeilnejad S, Semnanian S, Javan M. Metformin Protects Myelin from Degeneration in A Mouse Model of Iysophosphatidylcholine-Induced Demyelination in The Optic Chiasm Cell J. 2021 Apr;23(1):119-128. PMID: 33650828", "BibTeX": "@article{33650828, title={Metformin Protects Myelin from Degeneration in A Mouse Model of Iysophosphatidylcholine-Induced Demyelination in The Optic Chiasm}, author={Esmaeilnejad S and Semnanian S and Javan M}, journal={Cell J}, volume={23}, number={1}, pages={119-128}}"}}, {"_id": "37442896", "pmid": 37442896, "pmcid": "PMC10514123", "title": "Pathogenic Role of Fibrinogen in the Neuropathology of Multiple Sclerosis: A Tale of Sorrows and Fears", "journal": "Neurochem Res", "authors": ["Alruwaili M", "Al-Kuraishy HM", "Alexiou A", "Papadakis M", "ALRashdi BM", "Elhussieny O", "Saad HM", "Batiha GE"], "date": "2023-07-13T00:00:00Z", "doi": "10.1007/s11064-023-03981-1", "meta_date_publication": "2023 Jul 13", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50266.19, "text_hl": "Therefore, targeting of @GENE_FGB @GENE_2244 @@@fibrinogen@@@ and/or @GENE_ITGAM @GENE_3684 @@@CD11b@@@/CD18 receptors by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and statins might decrease @<m>DISEASE_Multiple_Sclerosis</m> @DISEASE_MESH:D009103 @@@MS neuropathology@@@. ", "citations": {"NLM": "Alruwaili M, Al-Kuraishy HM, Alexiou A, Papadakis M, ALRashdi BM, Elhussieny O, Saad HM, Batiha GE. Pathogenic Role of Fibrinogen in the Neuropathology of Multiple Sclerosis: A Tale of Sorrows and Fears Neurochem Res. 2023 Jul 13;():. PMID: 37442896", "BibTeX": "@article{37442896, title={Pathogenic Role of Fibrinogen in the Neuropathology of Multiple Sclerosis: A Tale of Sorrows and Fears}, author={Alruwaili M and Al-Kuraishy HM and Alexiou A and Papadakis M and ALRashdi BM and Elhussieny O and Saad HM and Batiha GE}, journal={Neurochem Res}}"}}, {"_id": "35583058", "pmid": 35583058, "title": "[Metformin activates AMPK to alleviate acute fulminant hepatitis induced by concanavalin A in mice].", "journal": "Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi", "authors": ["Liu Q", "Tian H", "Yang H", "Kang X", "Liu H", "Yang X", "Luo X", "Fan W"], "date": "2022-04-01T00:00:00Z", "meta_date_publication": "2022 Apr", "meta_volume": "38", "meta_issue": "4", "meta_pages": "302-307", "score": 50259.28, "text_hl": "[@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ activates AMPK to alleviate @<m>DISEASE_Multiple_Sclerosis</m> @DISEASE_MESH:D009103 @@@acute fulminant hepatitis@@@ induced by concanavalin A in @SPECIES_10090 @@@mice@@@].", "citations": {"NLM": "Liu Q, Tian H, Yang H, Kang X, Liu H, Yang X, Luo X, Fan W. [Metformin activates AMPK to alleviate acute fulminant hepatitis induced by concanavalin A in mice]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2022 Apr;38(4):302-307. PMID: 35583058", "BibTeX": "@article{35583058, title={[Metformin activates AMPK to alleviate acute fulminant hepatitis induced by concanavalin A in mice].}, author={Liu Q and Tian H and Yang H and Kang X and Liu H and Yang X and Luo X and Fan W}, journal={Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi}, volume={38}, number={4}, pages={302-307}}"}}, {"_id": "37397787", "pmid": 37397787, "pmcid": "PMC10312383", "title": "Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes", "journal": "Drug Des Devel Ther", "authors": ["Dutta S", "Shah RB", "Singhal S", "Dutta SB", "Bansal S", "Sinha S", "Haque M"], "date": "2023-06-26T00:00:00Z", "doi": "10.2147/DDDT.S409373", "meta_date_publication": "2023", "meta_volume": "17", "meta_issue": "", "meta_pages": "1907-1932", "score": 50256.766, "text_hl": "Preclinical studies have also shown some evidence of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@'s neuroprotective role in @DISEASE_Parkinson_Disease @DISEASE_MESH:D010300 @@@Parkinson's disease@@@, @DISEASE_Alzheimer_Disease @DISEASE_MESH:D000544 @@@Alzheimer's disease@@@, @<m>DISEASE_Multiple_Sclerosis</m> @DISEASE_MESH:D009103 @@@multiple sclerosis@@@ and @DISEASE_Huntington_Disease @DISEASE_MESH:D006816 @@@Huntington's disease@@@. ", "citations": {"NLM": "Dutta S, Shah RB, Singhal S, Dutta SB, Bansal S, Sinha S, Haque M. Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes Drug Des Devel Ther. 2023;17():1907-1932. PMID: 37397787", "BibTeX": "@article{37397787, title={Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes}, author={Dutta S and Shah RB and Singhal S and Dutta SB and Bansal S and Sinha S and Haque M}, journal={Drug Des Devel Ther}, volume={17}, pages={1907-1932}}"}}, {"_id": "40283923", "pmid": 40283923, "title": "Overview of Metformin and Neurodegeneration: A Comprehensive Review.", "journal": "Pharmaceuticals (Basel)", "authors": ["Kruczkowska W", "Gałęziewska J", "Buczek P", "Płuciennik E", "Kciuk M", "Śliwińska A"], "date": "2025-03-28T00:00:00Z", "doi": "10.3390/ph18040486", "meta_date_publication": "2025 Mar 28", "meta_volume": "18", "meta_issue": "4", "meta_pages": "", "score": 50253.44, "text_hl": "Originally used as a first-line treatment for @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@, recent studies have begun investigating @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@'s effects beyond @DISEASE_Metabolic_Diseases @DISEASE_MESH:D008659 @@@metabolic disorders@@@, particularly its neuroprotective capabilities against conditions like @DISEASE_Parkinson_Disease @DISEASE_MESH:D010300 @@@Parkinson's disease@@@, @DISEASE_Alzheimer_Disease @DISEASE_MESH:D000544 @@@Alzheimer's disease@@@, @DISEASE_Huntington_Disease @DISEASE_MESH:D006816 @@@Huntington's disease@@@, and @<m>DISEASE_Multiple_Sclerosis</m> @DISEASE_MESH:D009103 @@@multiple sclerosis@@@. ", "citations": {"NLM": "Kruczkowska W, Gałęziewska J, Buczek P, Płuciennik E, Kciuk M, Śliwińska A. Overview of Metformin and Neurodegeneration: A Comprehensive Review. Pharmaceuticals (Basel). 2025 Mar 28;18(4):. PMID: 40283923", "BibTeX": "@article{40283923, title={Overview of Metformin and Neurodegeneration: A Comprehensive Review.}, author={Kruczkowska W and Gałęziewska J and Buczek P and Płuciennik E and Kciuk M and Śliwińska A}, journal={Pharmaceuticals (Basel)}, volume={18}, number={4}}"}}, {"_id": "37904733", "pmid": 37904733, "pmcid": "PMC10613472", "title": "The AMPK activator metformin improves recovery from demyelination by shifting oligodendrocyte bioenergetics and accelerating OPC differentiation", "journal": "Front Cell Neurosci", "authors": ["Narine M", "Azmi MA", "Umali M", "Volz A", "Colognato H"], "date": "2023-10-12T00:00:00Z", "doi": "10.3389/fncel.2023.1254303", "meta_date_publication": "2023", "meta_volume": "17", "meta_issue": "", "meta_pages": "1254303", "score": 50252.414, "text_hl": "This finding broadens our knowledge of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@'s potential to promote myelin repair in @<m>DISEASE_Multiple_Sclerosis</m> @DISEASE_MESH:D009103 @@@MS@@@ and in other diseases with @DISEASE_Demyelinating_Diseases @DISEASE_MESH:D003711 @@@myelin loss@@@ or altered myelination dynamics.", "citations": {"NLM": "Narine M, Azmi MA, Umali M, Volz A, Colognato H. The AMPK activator metformin improves recovery from demyelination by shifting oligodendrocyte bioenergetics and accelerating OPC differentiation Front Cell Neurosci. 2023;17():1254303. PMID: 37904733", "BibTeX": "@article{37904733, title={The AMPK activator metformin improves recovery from demyelination by shifting oligodendrocyte bioenergetics and accelerating OPC differentiation}, author={Narine M and Azmi MA and Umali M and Volz A and Colognato H}, journal={Front Cell Neurosci}, volume={17}, pages={1254303}}"}}, {"_id": "33184094", "pmid": 33184094, "title": "Systematic approach to selecting licensed drugs for repurposing in the treatment of progressive multiple sclerosis.", "journal": "J Neurol Neurosurg Psychiatry", "authors": ["Cunniffe N", "Vuong KA", "Ainslie D", "Baker D", "Beveridge J", "Bickley S", "Camilleri P", "Craner M", "Fitzgerald D", "de la Fuente AG", "Giovannoni G", "Gray E", "Hazlehurst L", "Kapoor R", "Kaur R", "Kozlowski D", "Lumicisi B", "Mahad D", "Neumann B", "Palmer A", "Peruzzotti-Jametti L", "Pluchino S", "Robertson J", "Rothaul A", "Shellard L", "Smith KJ", "Wilkins A", "Williams A", "Coles A"], "date": "2021-03-01T00:00:00Z", "doi": "10.1136/jnnp-2020-324286", "meta_date_publication": "2021 Mar", "meta_volume": "92", "meta_issue": "3", "meta_pages": "295-302", "score": 50252.05, "text_hl": "RESULTS: From a short list of 55 treatments, we recommended four treatments for immediate testing in progressive @<m>DISEASE_Multiple_Sclerosis</m> @DISEASE_MESH:D009103 @@@MS@@@: R-alpha-lipoic acid, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, the combination treatment of R-alpha-lipoic acid and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, and @CHEMICAL_Niacin @CHEMICAL_MESH:D009525 @@@niacin@@@. ", "citations": {"NLM": "Cunniffe N, Vuong KA, Ainslie D, Baker D, Beveridge J, Bickley S, Camilleri P, Craner M, Fitzgerald D, de la Fuente AG, Giovannoni G, Gray E, Hazlehurst L, Kapoor R, Kaur R, Kozlowski D, Lumicisi B, Mahad D, Neumann B, Palmer A, Peruzzotti-Jametti L, Pluchino S, Robertson J, Rothaul A, Shellard L, Smith KJ, Wilkins A, Williams A, Coles A. Systematic approach to selecting licensed drugs for repurposing in the treatment of progressive multiple sclerosis. J Neurol Neurosurg Psychiatry. 2021 Mar;92(3):295-302. PMID: 33184094", "BibTeX": "@article{33184094, title={Systematic approach to selecting licensed drugs for repurposing in the treatment of progressive multiple sclerosis.}, author={Cunniffe N and Vuong KA and Ainslie D and Baker D and Beveridge J and Bickley S and Camilleri P and Craner M and Fitzgerald D and de la Fuente AG and Giovannoni G and Gray E and Hazlehurst L and Kapoor R and Kaur R and Kozlowski D and Lumicisi B and Mahad D and Neumann B and Palmer A and Peruzzotti-Jametti L and Pluchino S and Robertson J and Rothaul A and Shellard L and Smith KJ and Wilkins A and Williams A and Coles A}, journal={J Neurol Neurosurg Psychiatry}, volume={92}, number={3}, pages={295-302}}"}}, {"_id": "35132603", "pmid": 35132603, "title": "Cytokine Storm and Failed Resolution in COVID-19: Taking a Cue from Multiple Sclerosis.", "journal": "Adv Exp Med Biol", "authors": ["Zahoor I", "Li Y", "Rattan R", "Giri S"], "date": "2021-01-01T00:00:00Z", "doi": "10.1007/978-3-030-85109-5_13", "meta_date_publication": "2021", "meta_volume": "1352", "meta_issue": "", "meta_pages": "211-222", "score": 50251.586, "text_hl": "Accordingly, taking a cue from our experiences in controlling robust @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ response in @<m>DISEASE_Multiple_Sclerosis</m> @DISEASE_MESH:D009103 @@@MS@@@ and @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ by simultaneously inhibiting @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ process and stimulating its resolution, combinatorial therapy of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and SPM in @DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@COVID-19@@@ holds significant promise in treating this global health crisis.", "citations": {"NLM": "Zahoor I, Li Y, Rattan R, Giri S. Cytokine Storm and Failed Resolution in COVID-19: Taking a Cue from Multiple Sclerosis. Adv Exp Med Biol. 2021;1352():211-222. PMID: 35132603", "BibTeX": "@article{35132603, title={Cytokine Storm and Failed Resolution in COVID-19: Taking a Cue from Multiple Sclerosis.}, author={Zahoor I and Li Y and Rattan R and Giri S}, journal={Adv Exp Med Biol}, volume={1352}, pages={211-222}}"}}, {"_id": "34323699", "pmid": 34323699, "title": "Evaluation of the effects of metformin as adenosine monophosphate-activated protein kinase activator on spatial learning and memory in a rat model of multiple sclerosis disease.", "journal": "Biomed Pharmacother", "authors": ["Arabmoazzen S", "Mirshekar MA"], "date": "2021-09-01T00:00:00Z", "doi": "10.1016/j.biopha.2021.111932", "meta_date_publication": "2021 Sep", "meta_volume": "141", "meta_issue": "", "meta_pages": "111932", "score": 50250.88, "text_hl": "Evaluation of the effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as @GENE_PRKAA2 @GENE_78975 @@@adenosine monophosphate-activated protein kinase@@@ activator on spatial learning and memory in a @SPECIES_10116 @@@rat@@@ model of @<m>DISEASE_Multiple_Sclerosis</m> @DISEASE_MESH:D009103 @@@multiple sclerosis disease@@@.", "citations": {"NLM": "Arabmoazzen S, Mirshekar MA. Evaluation of the effects of metformin as adenosine monophosphate-activated protein kinase activator on spatial learning and memory in a rat model of multiple sclerosis disease. Biomed Pharmacother. 2021 Sep;141():111932. PMID: 34323699", "BibTeX": "@article{34323699, title={Evaluation of the effects of metformin as adenosine monophosphate-activated protein kinase activator on spatial learning and memory in a rat model of multiple sclerosis disease.}, author={Arabmoazzen S and Mirshekar MA}, journal={Biomed Pharmacother}, volume={141}, pages={111932}}"}}]}